U.S. needs clear policy on stem cell research, expert says

11/23/2010 | Philadelphia Inquirer, The

Congress needs to craft clear, comprehensive policy on research that uses stem cells derived from human embryos to end legal ambiguity surrounding such research, said John Gearhart, a stem cell pioneer and head of the University of Pennsylvania's Institute for Regenerative Medicine. An appeals court will conduct a hearing in December to discuss the legality of providing federal funding for embryonic stem cell research.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Paralegal
Mylan Inc.
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director of Actuarial Services, Government Programs
PacificSource
Springfield, OR
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA